Collegium to Present at Upcoming Investor Conferences
The Jefferies London Healthcare Conference onThursday, November 17th at12:40 p.m. GMT at theWaldorf Hilton London Hotel - The 28th Annual
Piper Jaffray Healthcare Conference onWednesday, November 30th at12:00 p.m. EST at theLotte New York Palace Hotel
About
Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its proprietary DETERx® technology platform for the treatment of chronic pain and other diseases. The DETERx technology platform is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.
About Xtampza ER
Xtampza® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the
Contact:Douglas Carlson Vice President, Corporate Development dcarlson@collegiumpharma.com